Literature DB >> 23627814

Adenoma, advanced adenoma and colorectal cancer prevalence in asymptomatic 40- to 49-year-old subjects with a first-degree family history of colorectal cancer.

G Del Vecchio Blanco1, M Cretella, O A Paoluzi, A Caruso, E Mannisi, F Servadei, S Romeo, E Grasso, P Sileri, M Giannelli, L Biancone, G Palmieri, F Pallone.   

Abstract

AIM: First-degree relatives (FDRs) of patients with colorectal cancer (CRC) have an increased CRC risk. Few studies have addressed if adenoma and advanced adenoma risk is increased among individuals, 40-49 years of age, with a family history of CRC. Therefore, the aim of the study was to define the prevalence and location of adenoma, advanced adenoma and CRC, according to age, in asymptomatic individuals with a family history of CRC.
METHOD: Retrospective study of asymptomatic FDRs, 40 to ≥70 years of age undergoing first screening colonoscopy over a 3-year period, of CRC patients.
RESULTS: Among 464 individuals studied, the prevalence of adenoma and advanced adenoma was 18.1% and 6.4%, respectively. According to age intervals, the prevalences of adenoma and advanced adenoma were 14% and 3.5%, respectively, in subjects 40-49 years of age; 14.4% and 6.3%, respectively, in subjects 50-59 years of age; 27% and 8%, respectively, in subjects 60-69 years of age; and 25% and 14%, respectively, in subjects ≥70 years of age; no significant difference was found among the four groups. No difference in lesion location was found, with similar numbers of preneoplastic lesions being present in the right colon and the left colon. CRC was diagnosed in three (0.64%) subjects, one of whom was in the 40-49 years age group.
CONCLUSION: In our population of FDRs of CRC patients, 40-49 years of age, the prevalences of adenoma and advanced adenoma were similar to those observed in older subjects with the same CRC risk. Our data support the current indication to perform screening colonoscopy earlier than 45 years of age in subjects at high CRC risk. Colorectal Disease
© 2013 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Adenoma; advanced adenoma; colonoscopy; colorectal cancer; screening colonoscopy

Mesh:

Year:  2013        PMID: 23627814     DOI: 10.1111/codi.12263

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  8 in total

1.  Invitation to Screening Colonoscopy in the Population at Familial Risk for Colorectal Cancer.

Authors:  Alexander Bauer; Jürgen F Riemann; Thomas Seufferlein; Max Reinshagen; Stephan Hollerbach; Ulrike Haug; Susanne Unverzagt; Stephanie Boese; Madeleine Ritter-Herschbach; Patrick Jahn; Thomas Frese; Michael Harris; Margarete Landenberger
Journal:  Dtsch Arztebl Int       Date:  2018-10-26       Impact factor: 5.594

Review 2.  Familial colorectal cancer: a review.

Authors:  Franco Armelao; Giovanni de Pretis
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

Review 3.  Familial colorectal cancer screening: When and what to do?

Authors:  Giovanna Del Vecchio Blanco; Omero Alessandro Paoluzi; Pierpaolo Sileri; Piero Rossi; Giuseppe Sica; Francesco Pallone
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 4.  Systematic Review of Prevalence, Risk Factors, and Risk for Metachronous Advanced Neoplasia in Patients With Young-Onset Colorectal Adenoma.

Authors:  Ngozi Enwerem; Moo Y Cho; Joshua Demb; Ashley Earles; Karen M Heskett; Lin Liu; Siddharth Singh; Samir Gupta
Journal:  Clin Gastroenterol Hepatol       Date:  2020-05-16       Impact factor: 11.382

5.  Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test.

Authors:  O Otero-Estévez; L De Chiara; F J Rodríguez-Berrocal; M Páez de la Cadena; J Cubiella; I Castro; C Gonzalez-Mao; V Hernandez; V S Martínez-Zorzano
Journal:  Br J Cancer       Date:  2014-12-02       Impact factor: 7.640

6.  Value of Serum NEUROG1 Methylation for the Detection of Advanced Adenomas and Colorectal Cancer.

Authors:  Olalla Otero-Estévez; María Gallardo-Gomez; María Páez de la Cadena; Francisco Javier Rodríguez-Berrocal; Joaquín Cubiella; Vicent Hernandez Ramirez; Laura García-Nimo; Loretta De Chiara
Journal:  Diagnostics (Basel)       Date:  2020-06-28

7.  Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer.

Authors:  Olalla Otero-Estévez; Loretta De Chiara; Leticia Barcia-Castro; María Páez de la Cadena; Francisco Javier Rodríguez-Berrocal; Joaquín Cubiella; Vicent Hernández; Vicenta Soledad Martínez-Zorzano
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

8.  Proximal shift of colorectal cancer with increasing age in different ethnicities.

Authors:  Lin Yang; Zhenchong Xiong; Wenzhuo He; Kunqian Xie; Shousheng Liu; Pengfei Kong; Chang Jiang; Guifang Guo; Liangping Xia
Journal:  Cancer Manag Res       Date:  2018-08-15       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.